Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Science (New York, N.Y.)|January 1, 2026
Quantifying host-microbe interactions with bacterial lineage tracingIan W Campbell, Karthik Hullahalli, Matthew K Waldor
Frontiers in Oncology|January 6, 2022
Orphan Medicinal Products for the Treatment of Pancreatic Cancer: Lessons Learned From Two Decades of Orphan DesignationJorn Mulder, Tobias van Rossum, Segundo Mariz, et al.
Drug Discovery Today|June 26, 2017
Establishing rarity in the context of orphan medicinal product designation in the European UnionStelios Tsigkos, Matthias Philipp Hofer, Maria Elzbieta Sheean, et al.
Archives of Disease in Childhood|November 2, 2017
Comparative analysis of the scope of European Union paediatric investigation plans with corresponding orphan designationsAndrea Ecker, Segundo Mariz, Frauke Naumann-Winter, et al.
Diabetes, Obesity & Metabolism|February 4, 2020
Metformin and cardiorenal outcomes in diabetes: A reappraisalJohn R Petrie, Peter R Rossing, Ian W Campbell
Orphanet Journal of Rare Diseases|December 6, 2014
Establishing medical plausibility in the context of orphan medicines designation in the European UnionStelios Tsigkos, Segundo Mariz, Jordi Llinares, et al.
Nature Communications|January 28, 2023
Quantitative dose-response analysis untangles host bottlenecks to enteric infectionIan W Campbell, Karthik Hullahalli, Jerrold R Turner, et al.
Advances in Therapy|April 13, 2026
Evaluating Cost-Effectiveness in Relation to the Supporting Clinical Evidence Across the Type 2 Diabetes Continuum: A Review of Metformin and SGLT2isIan W Campbell, Kerstin M G Brand, Ulrike Gottwald-Hostalek, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Quantification of Salmonella enterica serovar Typhimurium Population Dynamics in Murine Infection Using a Highly Diverse Barcoded LibraryJulia A Hotinger, Ian W Campbell, Karthik Hullahalli, et al.
Pageof 4